TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.854
EU - Europa 941
AS - Asia 408
SA - Sud America 6
OC - Oceania 1
Totale 3.210
Nazione #
US - Stati Uniti d'America 1.827
IT - Italia 245
IE - Irlanda 197
DE - Germania 187
SG - Singapore 162
CN - Cina 141
SE - Svezia 104
RU - Federazione Russa 87
HK - Hong Kong 52
CA - Canada 27
GB - Regno Unito 26
AT - Austria 23
FI - Finlandia 22
UA - Ucraina 20
TR - Turchia 16
VN - Vietnam 13
DK - Danimarca 11
ID - Indonesia 6
IN - India 6
JP - Giappone 6
NL - Olanda 5
FR - Francia 4
IL - Israele 4
BE - Belgio 3
CL - Cile 3
CZ - Repubblica Ceca 3
BR - Brasile 2
AU - Australia 1
BG - Bulgaria 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
KZ - Kazakistan 1
PL - Polonia 1
RO - Romania 1
Totale 3.210
Città #
Ann Arbor 508
Chandler 196
Dublin 192
Frankfurt am Main 168
Woodbridge 167
Singapore 135
Fairfield 129
Wilmington 90
Ashburn 71
New York 69
Hong Kong 52
Milan 49
Seattle 49
Houston 48
Princeton 48
Shanghai 45
Cambridge 41
Jacksonville 39
Lissone 34
Santa Clara 32
Dearborn 30
Altamura 23
Vienna 23
Lawrence 22
Beijing 16
Nanjing 16
Los Angeles 15
Lachine 11
Helsinki 10
Ottawa 10
Andover 9
Boardman 9
Caronno Pertusella 9
San Diego 9
Hangzhou 8
London 8
Shenyang 7
Jakarta 6
Melzo 6
Changsha 5
Jinan 5
Toronto 5
Bellaria-Igea Marina 4
Florence 4
Hebei 4
Messina 4
Norwalk 4
Pune 4
Romola 4
Sacramento 4
Tel Aviv 4
Zhengzhou 4
Brno 3
Brussels 3
Chicago 3
Cinisello Balsamo 3
Detroit 3
Guangzhou 3
Lardirago 3
Odense 3
Piacenza 3
Sesto San Giovanni 3
Verona 3
Aversa 2
Brescia 2
Cesano Maderno 2
Corbara 2
Cremona 2
Fremont 2
Genoa 2
Grassobbio 2
Jiaxing 2
Kunming 2
Monza 2
Munich 2
Nihon'odori 2
Orange 2
Padova 2
Redmond 2
Rome 2
Seregno 2
Tokyo 2
Vercelli 2
Almaty 1
Amsterdam 1
Belvedere Spinello 1
Biandronno 1
Bonndorf 1
Boston 1
Brugherio 1
Campinas 1
Cantù 1
Chengdu 1
Cusano Milanino 1
Dallas 1
Dalmine 1
Denton 1
Dnipro 1
Edmonton 1
Fuzhou 1
Totale 2.554
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 219
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 212
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 179
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 155
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 152
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 150
Neutrophil Extracellular Traps in the Autoimmunity Context 143
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 142
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 140
Immunology of membranous nephropathy: From animal models to humans 133
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 131
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 128
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 121
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 117
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 110
ANCA-associated vasculitides (AAV) from the gender point of view 109
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 107
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 102
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 98
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 91
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 88
Novel Therapies in Takayasu Arteritis 87
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 68
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 64
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 58
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 58
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 57
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 56
Evidence for charge-based mimicry in anti dsDNA antibody generation 53
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 21
Totale 3.349
Categoria #
all - tutte 12.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020158 0 0 0 4 11 18 19 21 21 20 26 18
2020/2021651 12 23 111 53 40 65 76 41 52 75 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/2025343 59 120 127 37 0 0 0 0 0 0 0 0
Totale 3.349